213 related articles for article (PubMed ID: 10828042)
1. Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation.
Condino-Neto A; Newburger PE
Blood; 2000 Jun; 95(11):3548-54. PubMed ID: 10828042
[TBL] [Abstract][Full Text] [Related]
2. Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation in CYBB gene.
Ishibashi F; Mizukami T; Kanegasaki S; Motoda L; Kakinuma R; Endo F; Nunoi H
Blood; 2001 Jul; 98(2):436-41. PubMed ID: 11435314
[TBL] [Abstract][Full Text] [Related]
3. An unusual intronic mutation in the CYBB gene giving rise to chronic granulomatous disease.
Noack D; Heyworth PG; Newburger PE; Cross AR
Biochim Biophys Acta; 2001 Sep; 1537(2):125-31. PubMed ID: 11566256
[TBL] [Abstract][Full Text] [Related]
4. Gene expression in chronic granulomatous disease and interferon-γ receptor-deficient cells treated in vitro with interferon-γ.
Frazão JB; Colombo M; Simillion C; Bilican A; Keller I; Wüthrich D; Zhu Z; Okoniewski MJ; Bruggmann R; Condino-Neto A; Newburger PE
J Cell Biochem; 2019 Mar; 120(3):4321-4332. PubMed ID: 30260027
[TBL] [Abstract][Full Text] [Related]
5. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
Okura Y; Yamada M; Kuribayashi F; Kobayashi I; Ariga T
J Clin Immunol; 2015 Feb; 35(2):158-67. PubMed ID: 25666294
[TBL] [Abstract][Full Text] [Related]
6. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
Condino-Neto A; Newburger PE
Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826
[TBL] [Abstract][Full Text] [Related]
7. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
Ezekowitz RA; Orkin SH; Newburger PE
J Clin Invest; 1987 Oct; 80(4):1009-16. PubMed ID: 2821069
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of interferon-gamma treatment to chronic granulomatous disease patients with splice site mutations.
Nunoi H; Ishibashi F; Mizukami T; Hidaka F
Jpn J Infect Dis; 2004 Oct; 57(5):S25-6. PubMed ID: 15507763
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation in the CYBB gene resulting in an unexpected pattern of exon skipping and chronic granulomatous disease.
Noack D; Heyworth PG; Curnutte JT; Rae J; Cross AR
Biochim Biophys Acta; 1999 Aug; 1454(3):270-4. PubMed ID: 10452961
[TBL] [Abstract][Full Text] [Related]
10. Targeted Repair of CYBB in X-CGD iPSCs Requires Retention of Intronic Sequences for Expression and Functional Correction.
Sweeney CL; Zou J; Choi U; Merling RK; Liu A; Bodansky A; Burkett S; Kim JW; De Ravin SS; Malech HL
Mol Ther; 2017 Feb; 25(2):321-330. PubMed ID: 28153086
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of NADPH oxidase in granulocytic cells expressing a delta488-497 gp91(phox) deletion mutant.
Yu L; Cross AR; Zhen L; Dinauer MC
Blood; 1999 Oct; 94(7):2497-504. PubMed ID: 10498623
[TBL] [Abstract][Full Text] [Related]
12. X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox.
Porter CD; Parkar MH; Levinsky RJ; Collins MK; Kinnon C
Blood; 1993 Oct; 82(7):2196-202. PubMed ID: 8400270
[TBL] [Abstract][Full Text] [Related]
13. X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.
Rae J; Newburger PE; Dinauer MC; Noack D; Hopkins PJ; Kuruto R; Curnutte JT
Am J Hum Genet; 1998 Jun; 62(6):1320-31. PubMed ID: 9585602
[TBL] [Abstract][Full Text] [Related]
14. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.
Leusen JH; Meischl C; Eppink MH; Hilarius PM; de Boer M; Weening RS; Ahlin A; Sanders L; Goldblatt D; Skopczynska H; Bernatowska E; Palmblad J; Verhoeven AJ; van Berkel WJ; Roos D
Blood; 2000 Jan; 95(2):666-73. PubMed ID: 10627478
[TBL] [Abstract][Full Text] [Related]
15. Enhanced generation of reactive oxygen species by interferon-γ may have contributed to successful treatment of invasive pulmonary aspergillosis in a patient with chronic granulomatous disease.
Yamashita K; Miyoshi T; Arai Y; Mizugishi K; Takaori-Kondo A; Ueyama T
Int J Hematol; 2013 Apr; 97(4):505-10. PubMed ID: 23526099
[TBL] [Abstract][Full Text] [Related]
16. Exon skipping in CYBB mRNA and skewed inactivation of X chromosome cause late-onset chronic granulomatous disease.
Eguchi M; Yagi C; Tauchi H; Kobayashi M; Ishii E; Eguchi-Ishimae M
Pediatr Hematol Oncol; 2018; 35(5-6):341-349. PubMed ID: 30633606
[TBL] [Abstract][Full Text] [Related]
17. CYBB mutation analysis in X-linked chronic granulomatous disease.
Jirapongsananuruk O; Niemela JE; Malech HL; Fleisher TA
Clin Immunol; 2002 Jul; 104(1):73-6. PubMed ID: 12139950
[TBL] [Abstract][Full Text] [Related]
18. A splice-supporting intronic mutation in the last bp position of a cryptic exon within intron 6 of the CYBB gene induces its incorporation into the mRNA causing chronic granulomatous disease (CGD).
Rump A; Rösen-Wolff A; Gahr M; Seidenberg J; Roos C; Walter L; Günther V; Roesler J
Gene; 2006 Apr; 371(2):174-81. PubMed ID: 16516412
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558.
Newburger PE; Skalnik DG; Hopkins PJ; Eklund EA; Curnutte JT
J Clin Invest; 1994 Sep; 94(3):1205-11. PubMed ID: 8083361
[TBL] [Abstract][Full Text] [Related]
20. The use of interferon-gamma therapy in chronic granulomatous disease.
Errante PR; Frazão JB; Condino-Neto A
Recent Pat Antiinfect Drug Discov; 2008 Nov; 3(3):225-30. PubMed ID: 18991804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
